Tumor desmoplasia outperforms preoperative serum calcitonin as surgical biomarker in sporadic medullary thyroid cancer.

Andreas Machens Kerstin LorenzClaudia BenschClaudia WickenhauserHenning Dralle

Published in: Head & neck (2024)

Thyroid tumor desmoplasia, unlike serum calcitonin levels, discriminates extremely well between node-negative and node-positive sporadic MTC, opening new avenues for precision surgery.

Keyphrases

late onset
lymph node
minimally invasive
amyotrophic lateral sclerosis
patients undergoing
coronary artery bypass
early onset
surgical site infection